You are here

Home > Current news > News > Companies

Companies

SOM Biotech i Vall d’Hebron assaig clínic fàrmac amiloïdosi

SOM Biotech and Vall d’Hebron successfully complete clinical trial in patients with amyloidosis drug

20.11.2015

It is a rare disease that affects the nervous system and heart, with only one treatment in the world

Transplant Biomedicals

Transplant Biomedicals closes €1.5-millions round of funding

18.11.2015

The capital increase, led by Kereon Partners, will allow the start-up to develop and market its first product, a medical device to better preserve and transport transplant organs

Carles Domenech, director general Ability Pharma

Ability Pharma successfully completes phase 1/1b clinical trial of ABTL0812 in advanced cancer patients with solid tumors

06.11.2015

The results come on the heels of the drug receiving FDA designation as an orphan drug

Oryzon genomics

Oryzon Genomics raises €16.5 millions and prepares to go public by year’s end

30.10.2015

This capital increase confirms the company is valued at €96.5 millions ahead of IPO

Grants4app

Bayer welcomes four healthcare technology start-up to its facilities under the ‘Grants4Apps’ Barcelona program

28.10.2015

The projects selected are from the fields of cardiology, neurology and diagnostic imaging

Rosendo Garganta Devicare
27.10.2015

Rosendo Garganta

Founder and CEO of Devicare

Industrial engineer and electronic engineer, Rosendo was lured away by the siren call of entrepreneurialism in the health and medtech sector. After studying business administration, entrepreneurship and innovation, he founded the medtech start-up Devicare. He is also a small investor and/or board member at start-ups Rob Surgical, usMIMA and Anaconda Biomed.

Palobiopharma

Biotechnology firm Palobiofarma signs licensing agreement with Novartis for Immunotherapy to treat cancer

28.10.2015

The Swiss multinational corporation will have the exclusive rights to develop, manufacture and market the product worldwide

Martinell Minoryx

Minoryx gets most significant funding in biotech sector in Catalonia

15.10.2015

The company, which specializes in drug development for rare or minority diseases without treatment, has received €19.4

ab biotics sanofi

Sanofi and AB-Biotics create formula to ease colic in babies

13.10.2015

The probiotic formula, developed by the Catalan biotechnology company, will be the first that pharmaceutical corporation Sanofi will market in Spain

Health & Bio Team Dating 2015

'Health & Bio Team Dating', initiative to pair up scientists and managers

08.10.2015

The event, organized by Banc Sabadell, Biocat, CataloniaBio and the Bosch i Gimpera Foundation, will take place in Barcelona on 3 December

Developed by Drauta